Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1106 | 50 | 0.8088 | 0.7554 | 0.0452 | 0.0454 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 14559 | 660 | 0.7276 | 0.7489 | 0.0453 | 0.0459 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 950 | 43 | 0.8907 | 0.8036 | 0.0453 | 0.0497 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 1676 | 76 | 0.5219 | 0.5199 | 0.0453 | 0.0507 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 2714 | 123 | 0.8451 | 0.7294 | 0.0453 | 0.0484 |
A-375 | Vemurafenib | I-BET151 | 0.100 | 1.000 | uM | 72 | hr | 1 | 4645 | 211 | 0.3205 | 0.2971 | 0.0454 | 0.0480 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 1620 | 74 | 0.9526 | 1.0000 | 0.0457 | 0.0422 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 1 | 4909 | 225 | 0.3435 | 0.3080 | 0.0458 | 0.0484 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 721 | 33 | 0.6756 | 0.8036 | 0.0458 | 0.0497 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 653 | 30 | 0.4772 | 0.6038 | 0.0459 | 0.0460 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 1504 | 69 | 1.1449 | 1.0000 | 0.0459 | 0.0496 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3779 | 175 | 0.1727 | 0.1741 | 0.0463 | 0.0433 |
A-375 | Vemurafenib | Belinostat | 0.000 | 0.000 | uM | 72 | hr | 3 | 14239 | 660 | 1.0368 | 1.0000 | 0.0464 | 0.0803 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2653 | 123 | 0.7299 | 0.6853 | 0.0464 | 0.0479 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1204 | 56 | 0.0581 | 0.0636 | 0.0465 | 0.0545 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
WM-115 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 3 | 3136 | 146 | 0.8573 | 0.8519 | 0.0466 | 0.0498 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 2 | 3366 | 157 | 0.9846 | 1.0000 | 0.0466 | 0.0538 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 451 | 21 | 0.4354 | 0.6021 | 0.0466 | 0.0426 |
WM-115 | Vemurafenib | Belinostat | 0.000 | 0.000 | uM | 72 | hr | 1 | 3852 | 180 | 1.0529 | 1.0000 | 0.0467 | 0.0525 |
A-375 | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 3 | 8504 | 397 | 0.4410 | 0.4696 | 0.0467 | 0.0532 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1112 | 52 | 0.0537 | 0.0545 | 0.0468 | 0.0467 |
WM-115 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 1 | 3106 | 146 | 0.8487 | 0.8519 | 0.0470 | 0.0498 |
WM-115 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 3766 | 177 | 0.9702 | 1.0000 | 0.0470 | 0.0560 |